Since AXIALYS delivery systems are based on highly biocompatible molecules able to provide slow, controlled release of the carried ingredients, we consider that our delivery systems can be deployed in the pharmaceutical industry.

To optimize our R&D investment and maintain our independence, AXIALYS use the profit generated from the ‘faster to market’ nutraceuticals and cosmeceutical business, to fund new promising pharmaceutical opportunities.

The route to market for AXIALYS health care products is through partnering with a larger pharmaceutical company at the appropriate stage in a product’s development.